Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Articles online first > Giornale Italiano di Dermatologia e Venereologia 2017 Jan 12



Cite this article as


A Journal on Dermatology and Sexually Transmitted Diseases

Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311



Giornale Italiano di Dermatologia e Venereologia 2017 Jan 12

DOI: 10.23736/S0392-0488.17.05420-7


language: English

A single institute experience on melanoma prognosis: a long term follow-up

Emi DIKA 1, Marco A. CHESSA 1 , Giulia VERONESI 1, Giulia M. RAVAIOLI 1, Pier A. FANTI 1, Simone RIBERO 2, Giovanni TRIPEPI 3, Carlotta GURIOLI 1, Alessandro TRANIELLO GRADASSI 1, Martina LAMBERTINI 1, Annalisa PATRIZI 1

1 Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy; 2 University of Turin, Department of Medical Sciences, Section of Dermatology, Turin, Italy; 3 CNR-IFC, Research Unit of Reggio Calabria, Reggio Calabria, Italy


BACKGROUND: The prognosis of cutaneous melanoma is correlated to histopathologic parameters such as Breslow thickness, the presence of mitosis, ulceration and lymphatic involvement at the moment of the diagnosis. On the other hand, the prognostic value of parameters such as age, sex, and tumor localization are still a matter of debate. We evaluated herein the prognostic factors in melanoma patients during a long term follow- up (60 months).
METHODS: Melanoma patients presenting stage IB-III at diagnosis were included. Breslow thickness, ulceration, lymphatic involvement, patients’ age, sex and tumor localization were correlated to patients prognosis. Univariate Cox regressions and multivariate Cox proportional-hazards regression were performed. Successively, Kaplan- Meier was used for variables significantly associated with overall melanoma survival.
RESULTS: 115 melanoma patients were included in this study. During follow-up 82 (72.17%) patients survived and 33 (28.7%) died. In our dataset, Breslow thickness >2mm (p=0.0007), patients age >50 years (p=0.005) and positive sentinel lymph node (p=0.0003) seem to be the most important variables correlated with the presence of metastases at 5 years follow-up. However distant metastases were also observed during follow-up in 14/26 patients presenting negative sentinel lymph node at diagnosis.
CONCLUSIONS: Given the vital importance of target drugs and the newly introduced immunotherapies in cutaneous melanoma management, we would suggest that mutational analyses should also be extended to the subgroup of patients presenting microstaging parameters related with a poor prognosis in a long term follow-up of 60 months.

KEY WORDS: Melanoma - Histopathology - Prognosis - Sentinel lymph node biopsy - Breslow – Age - Ulceration - Staging

top of page

Publication History

Cite this article as

Dika E, Chessa MA, Veronesi G, Ravaioli GM, Fanti PA, Ribero S, et al. A single institute experience on melanoma prognosis: a long term follow-up. G Ital Dermatol Venereol 2017 Jan 12. DOI: 10.23736/S0392-0488.17.05420-7 

Corresponding author e-mail